Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2013-04-04

Clinical Trial Update: Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

View source ↗

Summary

This clinical trial update describes safety and efficacy data for VariZIG (varicella zoster immune globulin, human) in patients at risk of varicella infection a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VariZIG (Varicella Zoster Immune Globulin (Human))

Snippet

Sponsor: Cangene Corporation | Conditions: Varicella | Status: APPROVED_FOR_MARKETING